The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM plus and CNS plus Mature B-NHL: A Children's Oncology Group Report

被引：0

作者：

Goldman, Stanton ^{[1
]}

Galardy, Paul J. ^{[2
]}

Smith, Lynette ^{[3
]}

Perkins, Sherrie L. ^{[4
,5
]}

Shiramizu, Bruce ^{[6
]}

Gross, Thomas ^{[7
]}

Sanger, Warren G. ^{[8
]}

Harrison, Lauren ^{[9
]}

Cairo, Mitchell S. ^{[9
]}

机构：

[1] Med City Childrens, Dallas, TX USA

[2] Mayo Clin, Rochester, MN USA

[3] Univ Nebraska Med Ctr, COPH Biostat, Omaha, NE USA

[4] Univ Utah, Dept Pathol, Salt Lake City, UT USA

[5] ARUP Labs, Salt Lake City, UT USA

[6] Univ Hawaii, Honolulu, HI 96822 USA

[7] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA

[8] Univ Nebraska, Med Ctr, Human Genet Lab, Omaha, NE USA

[9] New York Med Coll, Valhalla, NY 10595 USA

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1161 / 1162

页数：2

共 47 条

[31] A study of rituximab and ifosfamide, carboplatin, etoposide (ICE) chemotherapy in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute lymphoblastic leukemia (B-ALL). A children's oncology group report
Griffin, T.
Weitzman, S.
Weinstein, H.
Chang, M.
Hutchison, R.
ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
[32] Mabthera (Rituximab) plus CVP chemotherapy for first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma (NHL): Confirmed efficacy with longer follow-up.
Solal-Celigny, P
Imrie, K
Belch, A
Robinson, KS
Cunningham, D
Rueda, A
Catalano, J
Offner, F
Walewski, J
Raposo, J
Smith, P
Marcus, R
BLOOD, 2005, 106 (11) : 106A - 106A
[33] Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group
DuBois, Steven G.
Krailo, Mark D.
Glade-Bender, Julia
Buxton, Allen
Laack, Nadia
Randall, R. Lor
Chen, Helen X.
Seibel, Nita L.
Boron, Matthew
Terezakis, Stephanie
Hill-Kayser, Christine
Hayes, Andrea
Reid, Joel M.
Teot, Lisa
Rakheja, Dinesh
Womer, Richard
Arndt, Carola
Lessnick, Stephen L.
Crompton, Brian D.
Kolb, E. Anders
Daldrup-Link, Heike
Eutsler, Eric
Reed, Damon R.
Janeway, Katherine A.
Gorlick, Richard G.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) : 2098 - +
[34] A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children's Cancer Group
Gao, Yi-Jin
Fang, Yong-Jun
Gao, Ju
Yan, Jie
Yang, Liang-Chun
Liu, Ai-Guo
Ju, Xiu-Li
Lu, Jun
Han, Ya-Li
Wang, Jun
Xie, Min
Guo, Xia
Tang, Jing-Yan
ANNALS OF HEMATOLOGY, 2022, 101 (09) : 2035 - 2043
[35] A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group
Yi-Jin Gao
Yong-Jun Fang
Ju Gao
Jie Yan
Liang-Chun Yang
Ai-Guo Liu
Xiu-Li Ju
Jun Lu
Ya-Li Han
Jun Wang
Min Xie
Xia Guo
Jing-Yan Tang
Annals of Hematology, 2022, 101 : 2035 - 2043
[36] FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631
Patrick A. Brown
John A. Kairalla
Joanne M. Hilden
ZoAnn E. Dreyer
Andrew J. Carroll
Nyla A. Heerema
Cindy Wang
Meenakshi Devidas
Lia Gore
Wanda L. Salzer
Naomi J. Winick
William L. Carroll
Elizabeth A. Raetz
Michael J. Borowitz
Donald Small
Mignon L. Loh
Stephen P. Hunger
Leukemia, 2021, 35 : 1279 - 1290
[37] High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)
Nazemi, Kellie J.
Shen, Violet
Finlay, Jonathan L.
Boyett, James
Kocak, Mehmet
Lafond, Deborah
Gardner, Sharon L.
Packer, Roger J.
Nicholson, H. Stacy
PEDIATRIC BLOOD & CANCER, 2016, 63 (09) : 1563 - 1570
[38] Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031
Friedman, Debra L.
Chen, Lu
Wolden, Suzanne
Buxton, Allen
McCarten, Kathleen
FitzGerald, Thomas J.
Kessel, Sandra
De Alarcon, Pedro A.
Chen, Allen R.
Kobrinsky, Nathan
Ehrlich, Peter
Hutchison, Robert E.
Constine, Louis S.
Schwartz, Cindy L.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) : 3651 - 3658
[39] Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.
Minard-Colin, Veronique
Auperin, Anne
Pillon, Marta
Burke, Amos
Anderson, James Robert
Barkauskas, Donald A.
Wheatley, Keith
Delgado, Rafael
Alexander, Sarah
Uyttebroeck, Anne
Bollard, Catherine
Zsiros, Jozsef
Csoka, Monika
Goma, Gisele
Tulard, Anne
Patte, Catherine
Gross, Thomas G.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[40] Excellent outcomes in children and adolescents with central nervous system-positive (CNS+) Burkitt lymphoma/leukemia (BL) or other mature B-NHL using intrathecal and systemic chemotherapy without CNS irradiation: results from FAB/LMB96 and ANHL01P1 studies
Frazer, J. Kimble
Li, Kevin J.
Galardy, Paul
Perkins, Sherrie L.
Auperin, Anne
Anderson, James R.
Pinkerton, Ross
Buxton, Allen
Gross, Thomas G.
Weinstein, Howard
Harrison, Lauren
Shiramizu, Bruce
Barth, Matthew
Goldman, Stanton
Patte, Catherine
Cairo, Mitchell S.
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 6 - 7

← 1 2 3 4 5 →